awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38787405-99E6B5EA-E849-4903-8560-2BAB8BBFCC18
Q38787405-99E6B5EA-E849-4903-8560-2BAB8BBFCC18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38787405-99E6B5EA-E849-4903-8560-2BAB8BBFCC18
Immunotherapy approaches to treat adult acute lymphoblastic leukemia.
P2860
Q38787405-99E6B5EA-E849-4903-8560-2BAB8BBFCC18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38787405-99E6B5EA-E849-4903-8560-2BAB8BBFCC18
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
deee53d48bc47703c7eefe50fc1c8a39b07ffa3a
P2860
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.